(S (NP-SBJ (NN Adenovirus) (NN E1A)) (VP (VBZ inhibits) (NP (NP (JJ IFN-induced) (NN resistance)) (PP (TO to) (NP (NP (NN cytolysis)) (PP (IN by) (NP (JJ natural) (NN killer) (NNS cells))))))) (. .))
(S (NP-SBJ (NP (NN Infection)) (PP (IN of) (NP (NN target) (NNS cells))) (PP (IN with) (NP (JJ cytopathic) (NNS viruses)))) (VP (VBZ inhibits) (NP (NP (NP (NN IFN) (NN induction)) (PP (IN of) (NP (NP (JJ cytolytic) (NN resistance)) (PP (TO to) (NP (ADJP (NN NK) (JJ cell-mediated)) (NN cytolysis)))))) (PRN (-LRB- -LCB-) (NP (NP (JJ IFN-mediated) (NN cytoprotection)) (PRN (-LRB- -LRB-) (NP (NN IFN-MCP)) (-RRB- -RRB-))) (-RRB- -RCB-)))) (. .))
(S (NP-SBJ (PRP It)) (VP (VBZ has) (VP (VBN been) (VP (VBN thought) (SBAR (IN that) (S (NP-SBJ (NP (DT the) (ADJP (RB virally) (VBN induced)) (NN inhibition)) (PP (IN of) (NP (NN IFN-MCP)))) (VP (VBZ is) (ADJP-PRD (JJ secondary) (PP (TO to) (NP (NP (DT the) (NN shutdown)) (PP (IN of) (NP (NP (JJ cellular) (JJ macromolecular) (NN synthesis)) (SBAR (WHNP-33 (WDT that)) (S (NP-SBJ (-NONE- *T*-33)) (VP (VBZ accompanies) (NP (JJ cytopathic) (NN virus) (NNS infections)))))))))))))))) (. .))
(S (NP-SBJ (NN Group) (NN C) (, ,) (NP (NP (NN adenovirus) (NN serotype) (CD 5)) (PRN (-LRB- -LRB-) (NP (NN Ad5)) (-RRB- -RRB-))) (NN infection)) (VP (VBZ inhibits) (NP-COOD (CC both) (NP (NN IFN-MCP)) (CC and) (NP (JJ cellular) (NN protein) (NN synthesis)))) (. .))
(S (NP-SBJ (DT This) (NN study)) (VP (VBD determined) (SBAR (IN if) (S (NP-SBJ (NP (DT the) (JJ Ad5-induced) (NN inhibition)) (PP (IN of) (NP (NN IFN-MCP)))) (VP (VBD was) (ADJP-PRD-COOD (ADJP (JJ independent) (PP (IN of) (NP (NP (NP (NN adenovirus)) (PRN (-LRB- -LRB-) (NP (NN Ad)) (-RRB- -RRB-))) (NN infection)))) (CC and) (ADJP (JJ secondary) (PP (RB only) (TO to) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (DT the) (NN Ad) (NP (NP (JJ early) (NN region) (NN 1A) (NN gene)) (PRN (-LRB- -LRB-) (NP (NN E1A)) (-RRB- -RRB-))))))))))))) (. .))
(S (S (NP-SBJ (-NONE- *)) (VP (TO To) (VP (VB test) (NP (DT this) (NN hypothesis))))) (, ,) (NP-SBJ-34 (JJ 4-h) (NN NK) (NN cytolysis) (NNS assays)) (VP (VBD were) (VP (VBN performed) (NP (-NONE- *-34)) (PP (IN on) (NP (NP (JJ IFN-gamma-treated) (JJ human) (NNS cells)) (ADJP-COOD (ADJP (VBN infected) (PP (IN with) (NP (NP (DT an) (NN Ad5) (NN E1A) (NN deletion) (NN mutant)) (, ,) (NP (NN dl343))))) (, ,) (CC or) (ADJP (VBN transfected) (PP (IN with) (NP (DT the) (NN Ad5) (NN E1A) (NN gene))))))))) (. .))
(S (NP-SBJ-35 (NN IFN-MCP)) (VP (VBD was) (RB not) (VP (VBN inhibited) (NP (-NONE- *-35)) (PP (IN by) (NP-LGS (NP (NN infection)) (PP (IN with) (NP (NN dl343))))) (, ,) (PP (IN despite) (NP (NP (DT the) (NN production)) (PP (IN of) (NP (NP (JJ large) (NNS amounts)) (PP (IN of) (NP (NP-COOD (CC both) (NP (NP (JJ early) (NP (-NONE- *RNR*-36))) (PRN (-LRB- -LRB-) (NP-COOD (NP (NN E1B)) (, ,) (NP (NN p55))) (-RRB- -RRB-))) (CC and) (NP (NP (JJ late) (NP (-NONE- *RNR*-36))) (PRN (-LRB- -LRB-) (NP (NN hexon)) (-RRB- -RRB-)))) (NP-36 (NN Ad) (NNS proteins)))))))))) (. .))
(S (PP (IN In) (NN contrast) (TO to) (NP (ADJP-COOD (ADJP (JJ E1A-negative)) (, ,) (ADJP (JJ parental))) (NN cell) (NNS lines))) (, ,) (NP-SBJ-37 (NN IFN-MCP)) (VP (VBD was) (VP (VBN blocked) (NP (-NONE- *-37)) (PP (IN in) (NP (ADJP (NN Ad5) (JJ E1A-transfected)) (ADJP-COOD (ADJP (JJ epithelial)) (CC and) (ADJP (JJ fibroblastic))) (NN cell) (NNS lines))))) (. .))
(S (NP-SBJ (NP (JJ Genetic) (NN mapping) (NNS studies)) (PP (IN within) (NP (DT the) (NN E1A) (NN gene)))) (VP (VBD demonstrated) (SBAR (IN that) (S (NP-SBJ (NP (NN expression)) (PP (IN of) (NP (NP (RB only) (DT the) (JJ first) (NN exon)) (PP (IN of) (NP (NN E1A)))))) (VP (VBD was) (ADJP-PRD (JJ sufficient) (S (NP-SBJ (-NONE- *)) (VP (TO to) (VP (VB inhibit) (NP (NN IFN-MCP)))))))))) (. .))
(S (NP-SBJ-38 (NP (NN DNA) (NN sequence) (NN homology)) (PP (IN of) (NP (NN E1A) (NNS genes))) (PP (IN between) (NP (NP (JJ different) (NN Ad) (NNS groups)) (PRN (-LRB- -LRB-) (FRAG (FRAG (NP (NN group) (NN A)) (, ,) (NP (NN Ad12))) (: ;) (FRAG (NP (NN group) (NN C)) (, ,) (NP (NN Ad5)))) (-RRB- -RRB-))))) (VP (VBZ is) (VP (VBN limited) (NP (-NONE- *-38)) (PP (ADVP (RB almost) (RB entirely)) (TO to) (NP (NP (CD three) (VBN conserved) (NNS regions)) (ADJP (JJ located) (PP (IN within) (NP (NP (DT the) (JJ first) (NN exon)) (PP (IN of) (NP (NN E1A)))))))))) (. .))
(S (SBAR (IN Because) (S (NP-SBJ-39 (NN IFN-MCP)) (VP (VBD was) (ADVP (RB also)) (VP (VBN blocked) (NP (-NONE- *-39)) (PP (IN in) (NP (NN Ad12) (JJ E1A-transfected) (NN cell) (NNS lines))))))) (, ,) (NP-SBJ-100 (NP (NN expression)) (PP (IN of) (NP (NP (QP (CD one) (CC or) (JJR more))) (PP (IN of) (NP (DT the) (JJ E1A-conserved) (NNS regions)))))) (VP (MD may) (VP (VB be) (ADJP-PRD (JJ necessary) (S (NP-SBJ (-NONE- *-100)) (VP (TO to) (VP (VB inhibit) (NP (NN IFN-MCP)))))))) (. .))
(S (PP (IN In) (NP (NN summary))) (, ,) (NP-SBJ (NP (DT the) (NN expression)) (PP (IN of) (NP (NN E1A) (NN gene) (NNS products)))) (VP (VBD inhibited) (NP (NN IFN-MCP)) (ADVP (RB independently)) (PP (IN of) (NP (NN virus) (NN infection)))) (. .))
(S (NP-SBJ (NP (NP (NN E1A)) (POS 's)) (PP (NN inhibition) (NP (IN of)))) (VP (NN IFN-MCP) (NP (NP (VBZ has) (DT the) (JJ net)) (PP (NN effect) (S (NP-SBJ (-NONE- *)) (VP (IN of) (NP (NP (VBG promoting) (DT the) (ADJP (JJ selective) (NN NK)) (JJ cell-mediated)) (PP (NN clearance) (NP (ADJP-COOD (ADJP (IN of)) (JJ Ad-infected) (ADJP (CC or))) (JJ Ad-transformed) (JJ human))))))))) (NNS cells))
